Insulet welcomes Dr. Wayne Frederick to its Board of Directors and the Audit Committee

– USA, MA –  Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod Insulin Management System, today announced the appointment of Dr. Wayne Frederick, M.D. to its Board of Directors, effective immediately. He will also serve on the Board’s Audit Committee.

“We are delighted to welcome Dr. Frederick to Insulet’s Board,” said Board Chairman, Timothy Scannell. “Dr. Frederick’s highly accomplished track record and vast experience treating patients with complex diseases, conducting research, teaching, and leading large organizations will be tremendously beneficial to our Board as we continue to execute our global strategic growth initiatives.”

About Dr. Wayne Frederick

Dr. Frederick is the president of Howard University and serves as the Charles R. Drew Endowed Chair of Surgery at Howard University’s College of Medicine. Dr. Frederick is a practicing surgeon, distinguished researcher and scholar, and the author of numerous peer-reviewed articles, book chapters, abstracts, and editorials. Dr. Frederick is a highly regarded expert on disparities in healthcare and medical education and is focused on narrowing racial, ethnic, and gender disparities in cancer care outcomes among African Americans and other underrepresented groups. He has served as the principal investigator for major collaborations with the National Cancer Institute and Johns Hopkins University, as well as several national minority-serving oncology programs.

Dr. Frederick has received several awards for his scholarship and public service is a fellow of the American College of Surgeons and belongs to numerous surgical organizations, including the American Surgical Association. In addition to Insulet’s Board, Dr. Frederick serves on the Board of Directors of Humana Inc., Forma Therapeutics Holdings, Inc., and the Federal Reserve Bank of Richmond, along with other privately held companies and non-profit organizations.

About Insulet Corporation:

Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.